Skip to content
World clockEU--:--UK--:--USA--:--CN--:--PLDEFRIT中文EN

portal about AI and technologyevents · analysis · interviews · technical background

Search
LIVE
›

Health

212 texts · 4/12
Xencor picks 400 mcg/kg as Phase 3 dose for kidney cancer drug XmAb819

Xencor picks 400 mcg/kg as Phase 3 dose for kidney cancer drug XmAb819

Xencor said on 25 October it chose 400 mcg/kg as the proposed Phase 3 dose for XmAb819 in advanced clear cell renal cell carcinoma, after that dose produced a 45.5% confirmed response rate in 11 evaluable patients, a figure with a wide confidence interval.

Health6 November 20265 min readSources 18
Cleveland Clinic Lutheran Hospital workers ratify three-year contract

Cleveland Clinic Lutheran Hospital workers ratify three-year contract

Union members at Cleveland Clinic Lutheran Hospital ratified a three-year contract on 8 October, ending a strike that began on 23 September over healthcare costs. The deal includes nearly 11% in wage increases but does not specifically address premiums.

Health6 November 20263 min readSources 12
FDA extends Capricor's deramiocel decision date to 22 November

FDA extends Capricor's deramiocel decision date to 22 November

The FDA moved its decision date for Capricor Therapeutics' deramiocel to 22 November from 22 August, after advisers voted 9-3 against the Duchenne muscular dystrophy cardiomyopathy indication and Capricor narrowed its proposed use to upper-limb function.

Health6 November 20264 min readSources 13

Latest

11 texts
Cyberattack diverts ambulances from New Mexico's only Level I trauma center

Cyberattack diverts ambulances from New Mexico's only Level I trauma center

A cyberattack on UNM Health diverted ambulances from New Mexico's only Level I trauma center for two hours on 26 October and canceled outpatient surgeries, before critical systems came back online and clinics resumed scheduled care.

Health6 November 20264 min read
FDA places Bright Minds' BMB-101 DEE IND on partial clinical hold

FDA places Bright Minds' BMB-101 DEE IND on partial clinical hold

Bright Minds said on 2 November 2026 that the FDA placed its BMB-101 IND for developmental and epileptic encephalopathies and Protocol BMB-101-105 on partial clinical hold, citing mouse toxicity and inadequate pharmacokinetic and juvenile toxicity data. Shares closed 52.35% lower.

Health6 November 20264 min read
Philips books €288 million provision for US Justice Department recall settlement

Philips books €288 million provision for US Justice Department recall settlement

Philips said on Tuesday 3 November it had agreed in principle with the US Department of Justice over its Respironics recall. It booked a €288 million provision, and third-quarter net income fell to €28 million from €187 million.

Health6 November 20263 min read
04

Guinea-Bissau formally rejects US-funded hepatitis B vaccine trial

Guinea-Bissau's Council of Ministers formally rejected a US-funded hepatitis B vaccine trial on 16 October, co-lead Christine Stabell Benn told Ars Technica, ending a $3.2m study that planned to withhold the birth dose from 7,000 newborns.

Health6 November 20265 min read
05

NHS England waiting list rises to 7.37 million treatments, highest since October 2025

NHS England's waiting list for planned hospital treatment rose to 7.37 million treatments at the end of August 2026, up from 7.33 million in July and the highest since October 2025, figures published by NHS England show.

Health5 November 20263 min read
06

FDA grants accelerated approval to Inovio's VOCERYQ for recurrent respiratory papillomatosis

The FDA granted accelerated approval on 30 October 2026 to Inovio's VOCERYQ, a DNA medicine for adults with recurrent respiratory papillomatosis, a rare disease that often requires repeated airway surgery.

Health5 November 20264 min read
07

Providence Santa Rosa Memorial nurses begin two-day strike over pay and staffing

About 795 nurses represented by the Staff Nurses Association began a two-day strike at 5 a.m. on Tuesday 27 October over pay, break coverage and retirement benefits at the region's only Level II trauma center.

Health5 November 20263 min read
08

ChipSoft confirms patient data stolen in 7 April ransomware attack

ChipSoft has confirmed patient data was stolen in the ransomware attack that began on 7 April 2026, DutchNews reported, after telling clients data was "probably" safe. Its HiX software is used by about 70% of Dutch hospitals.

Health5 November 20264 min read
09

Lancet HIV publishes IMPAACT 2023 trial of dolutegravir in newborns

The Lancet HIV has published the phase 1 IMPAACT 2023 trial showing a dolutegravir dosing regimen reaches target drug levels in full-term newborns, evidence that supported the FDA's August 2026 approval of Tivicay PD from birth.

Health5 November 20264 min read
10

University Hospitals has no timeline for restoring systems after 22 October cyber incident

University Hospitals has not given a timeline for restoring systems including MyChart after a 22 October cyber incident, an internal letter obtained by 3News says, leaving electronic prescribing and the portal offline.

Health5 November 20263 min read
11

Gavi and UNICEF agree to cut RTS,S malaria vaccine price by about 40% to €5.50 a dose

Gavi and UNICEF said on 22 October 2026 that they had agreed to cut the price of the RTS,S/AS01 malaria vaccine by about 40% to €5.50 a dose from early 2027, saving around $50 million between 2027 and 2029.

Health5 November 20263 min read